These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29513042)

  • 1. Bioactive cyclic molecules and drug design.
    Newman DJ
    Expert Opin Drug Discov; 2018 May; 13(5):379-385. PubMed ID: 29513042
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progress in the study of some important natural bioactive cyclopeptides].
    Xu WY; Zhao SM; Zeng GZ; He WJ; Xu HM; Tan NH
    Yao Xue Xue Bao; 2012 Mar; 47(3):271-9. PubMed ID: 22645749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemistry and biology of cyclic depsipeptides of medicinal and biological interest.
    Sarabia F; Chammaa S; Ruiz AS; Ortiz LM; Herrera FJ
    Curr Med Chem; 2004 May; 11(10):1309-32. PubMed ID: 15134522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologically Active Orbitides from the Euphorbiaceae Family.
    Ramalho SD; Pinto MEF; Ferreira D; Bolzani VS
    Planta Med; 2018 Jul; 84(9-10):558-567. PubMed ID: 29169187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of cyclic peptides: vancomycin and oxytocin as paradigms.
    Schulze J
    Protein Pept Lett; 2014 Jun; 21(6):593-6. PubMed ID: 24559165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemistry. Rings of destruction.
    Ganz T
    Nature; 2001 Jul; 412(6845):392-3. PubMed ID: 11473296
    [No Abstract]   [Full Text] [Related]  

  • 7. Design and synthesis of 16-membered cyclopeptides active against vancomycin-resistant Enterococci (VRE).
    Zhu J
    Chimia (Aarau); 2013; 67(12-13):916-20. PubMed ID: 24594338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of multi-drug release coatings targeting infection and inflammation.
    Shukla A; Fuller RC; Hammond PT
    J Control Release; 2011 Oct; 155(2):159-66. PubMed ID: 21699932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new and improved method for deglycosidation of glycopeptide antibiotics exemplified with vancomycin, ristocetin, and ramoplanin.
    Wanner J; Tang D; McComas CC; Crowley BM; Jiang W; Moss J; Boger DL
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1169-73. PubMed ID: 12643936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bottromycin derivatives: efficient chemical modifications of the ester moiety and evaluation of anti-MRSA and anti-VRE activities.
    Kobayashi Y; Ichioka M; Hirose T; Nagai K; Matsumoto A; Matsui H; Hanaki H; Masuma R; Takahashi Y; Omura S; Sunazuka T
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6116-20. PubMed ID: 20833545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive activity of threonine-containing analogues of cyclolinopeptide A.
    Siemion IZ; Cebrat M; Lisowski M; Zimecki M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1992; 40(5-6):257-61. PubMed ID: 1340179
    [No Abstract]   [Full Text] [Related]  

  • 12. Design and synthesis of plant cyclopeptide Astin C analogues and investigation of their immunosuppressive activity.
    Li F; Guo XX; Zeng GZ; Qin WW; Zhang B; Tan NH
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2523-2527. PubMed ID: 29871844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rejection of long-surviving mouse skin allografts after withdrawal of cyclosporin A therapy.
    Lems SP; Capel PJ; Koene RA
    Transplant Proc; 1980 Jun; 12(2):283-6. PubMed ID: 6994296
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppressive activity of tyrosine analogues of cyclolinopeptide A.
    Wieczorek Z; Pedyczak A; Bodalski T; Lisowski M; Trojnar J; Zimecki M; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):213-6. PubMed ID: 1300986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A charge-adaptive nanosystem for prolonged and enhanced in vivo antibiotic delivery.
    Chu L; Gao H; Cheng T; Zhang Y; Liu J; Huang F; Yang C; Shi L; Liu J
    Chem Commun (Camb); 2016 May; 52(37):6265-8. PubMed ID: 27077219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of cardiac allografts in rats treated with cyclosporin A.
    Jamieson SW; Burton NA; Bieber CP; Reitz BA; Oyer PE; Stinson EB; Shumway NE
    Surg Forum; 1979; 30():289-91. PubMed ID: 395684
    [No Abstract]   [Full Text] [Related]  

  • 17. Thalassospiramides A and B, immunosuppressive peptides from the marine bacterium Thalassospira sp.
    Oh DC; Strangman WK; Kauffman CA; Jensen PR; Fenical W
    Org Lett; 2007 Apr; 9(8):1525-8. PubMed ID: 17373804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel polycationic analogue of gratisin with antibiotic activity against both Gram-positive and Gram-negative bacteria.
    Tamaki M; Kokuno M; Suzuki Y; Iwama M; Shindo M; Uchida Y
    J Antibiot (Tokyo); 2008 Jan; 61(1):33-5. PubMed ID: 18305357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic peptides yield promising antimicrobial results.
    Bradbury J
    Lancet Infect Dis; 2001 Sep; 1(2):71. PubMed ID: 11871472
    [No Abstract]   [Full Text] [Related]  

  • 20. FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase III. Structure determination.
    Mori H; Urano Y; Kinoshita T; Yoshimura S; Takase S; Hino M
    J Antibiot (Tokyo); 2003 Feb; 56(2):181-5. PubMed ID: 12715880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.